Preferences for chlamydia testing and management in Hong Kong: a discrete choice experiment

被引:0
|
作者
Ong, Jason J. [1 ,2 ]
Fairley, Christopher K. [1 ,2 ]
Hocking, Jane S. [3 ]
Turner, Katy M. E. [4 ]
Booton, Ross [4 ]
Tse, Desiree [5 ]
Wong, William W. C. W. [5 ,6 ]
机构
[1] Monash Univ, Cent Cllin Sch, Melbourne, Vic, Australia
[2] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Carlton, Vic, Australia
[4] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England
[5] Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Peoples R China
[6] Univ Hong Kong, Shenzhen Hosp, Dept Family Med & Primary Care, Shenzhen, Peoples R China
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
testing; management; chlamydia infections; health services research; INFECTIONS; VIEWS; WOMEN;
D O I
10.1136/sextrans-2021-055182
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives As most chlamydia cases are asymptomatic, regular testing and timely management may be necessary for control. We aimed to determine the preferences of people living in Hong Kong for chlamydia testing and management services. Methods An online panel of sexually active individuals living in Hong Kong completed the survey with two discrete choice experiments (DCEs). The first DCE examined the preferred attributes of a chlamydia testing service (cost, location, appointment time, speed of results, delivery of results and availability of other STI testing). The second DCE examined the preferred attributes of a chlamydia management service (cost, access to patient-delivered partner therapy, location, travel time, type of person consulted and attitude of staff). Results In total, 520 individuals participated: average age 36.8 years (SD 9.9), 40% males and 66% had a bachelor's degree or higher. Choosing to test was most influenced by cost, followed by speed of results, delivery of results, extra STI testing, appointment available and the least important was the location of testing. Choosing to attend for management was most influenced by staff's attitude, followed by cost, who they consult, access to patient-delivered partner therapy, travel time and the least important was treatment location. Conclusion To design effective chlamydia testing and management services, it is vital to respond to patient needs and preferences. For people living in Hong Kong, cost and staff attitude were the most important factors for deciding whether to test or be managed for chlamydia, respectively.
引用
收藏
页码:408 / 413
页数:6
相关论文
共 50 条
  • [1] PREFERENCES FOR CHLAMYDIA TESTING AND MANAGEMENT IN HONG KONG: A DISCRETE CHOICE EXPERIMENT
    Ong, J.
    Fairley, C.
    Hocking, J.
    Turner, K.
    Booton, R.
    Tse, D.
    Wong, W.
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2021, 97 : A139 - A140
  • [2] Mothers' Preferences and Willingness to Pay for Human Papillomavirus Vaccination for Their Daughters: A Discrete Choice Experiment in Hong Kong
    Wong, Carlos K. H.
    Man, Kenneth K. C.
    Ip, Patrick
    Kwan, Mike
    McGhee, Sarah M.
    [J]. VALUE IN HEALTH, 2018, 21 (05) : 622 - 629
  • [3] Young people's preferences for the use of emerging technologies for asymptomatic regular chlamydia testing and management: a discrete choice experiment in England
    Eaton, Sue
    Biggerstaff, Deborah
    Petrou, Stavros
    Osipenko, Leeza
    Gibbs, Jo
    Estcourt, Claudia S.
    Sadiq, Tariq
    Szczepura, Ala
    [J]. BMJ OPEN, 2019, 9 (01):
  • [4] Correction to: COVID-19 vaccine preferences among university students in Hong Kong: a discrete choice experiment
    Xue Li
    Man Yui Chong
    Ching Yui Chan
    Vindy Wing Sum Chan
    Xinning Tong
    [J]. BMC Research Notes, 14
  • [5] COVID-19 Vaccination Preferences Among Non-Chinese Migrants in Hong Kong: Discrete Choice Experiment
    Asim, Saba
    Wang, Kailu
    Nichini, Elena
    Yip, Faustina Fu
    Zhu, Liling
    Fung, Hin Chung Eddy
    Zeng, Yan
    Fang, Zhilan
    Cheung, Annie Wai-Ling
    Wong, Eliza Lai-yi
    Dong, Dong
    Yeoh, Eng-Kiong
    [J]. JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9
  • [6] Preferences for pharmacogenomic testing in polypharmacy patients: a discrete choice experiment
    Chen, Cheng
    Roberts, Melissa H.
    Raisch, Dennis W.
    Thompson, Todd A.
    Bachyrycz, Amy
    Borrego, Matthew E.
    [J]. PERSONALIZED MEDICINE, 2022, 19 (06) : 535 - 548
  • [7] PREFERENCES FOR PHARMACOGENOMIC TESTING IN POLYPHARMACY PATIENTS: A DISCRETE CHOICE EXPERIMENT
    Chen, C.
    Roberts, M.
    Raisch, D. W.
    Bachyrycz, A.
    Thompson, T.
    Borrego, M.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S573 - S573
  • [8] A PRELIMINARY COMPARISON BETWEEN ANALYTICAL HIERARCHY PROCESS AND DISCRETE CHOICE EXPERIMENT IN HEALTH STATE PREFERENCES IN HONG KONG SAR, CHINA
    Ng, C. C. W.
    Cheung, A. W. L.
    Wong, E.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S458 - S458
  • [9] Factors affecting young people's preferences for emerging technologies for chlamydia testing and treatment: a discrete choice experiment in England
    Eaton, Sue
    Biggerstaff, Deborah
    Pink, Joshua
    Petrou, Stavros
    Osipenko, Leeza
    Gibbs, Jo
    Estcourt, Claudia S.
    Sadiq, S. Tariq
    Szczepura, Ala
    [J]. LANCET, 2016, 388 : 44 - 44
  • [10] PATIENT PREFERENCES FOR DIABETES MANAGEMENT IN SPAIN - A DISCRETE CHOICE EXPERIMENT
    Munoz, A.
    Gomez-Peralta, F.
    Mareque, M.
    Maderuelo, M.
    Casado, M. A.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S213 - S214